Approaches towards Bone diseases
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Rotterdam
State: Zuid-Holland
Zip:
Country: The Netherlands
Therosteon is a new biotech fledgling emerging from the Erasmus Medical Center in Rotterdam (The Netherlands). The Company develops novel therapeutics for bone diseases including osteoporosis, osteoarthritis, and bone metastasis based on its OsteoBLAST technology platform. Bone diseases represent an interesting market opportunity, with huge unmet medical needs. Osteoporosis in itself represents a huge market opportunity with drug sales totaling 7 billion. Therosteon is located in incubator facilities of the Erasmus MC and collaborates closely with academic group of its scientific founder Prof. Hans van Leeuwen.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2008 | Venture Round | 1 | - |
Erasmus MC Biomedical Fund Erasmus MC Biomedical Fund |
4/2008 | Venture Round | 1 | - |
Erasmus MC Biomedical Fund Erasmus MC Biomedical Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|